Retrieve available abstracts of 135 articles: HTML format
Single Articles
April 2025
UYEKI TM, Dugan VG, Daskalakis DC Baloxavir Treatment to Reduce Influenza Virus Transmission.
N Engl J Med. 2025;392:1652-1654. PubMed
MONTO AS, Kuhlbusch K, Bernasconi C, Cao B, et al Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
N Engl J Med. 2025;392:1582-1593. PubMedAbstract available
February 2025
WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al VITT-like Monoclonal Gammopathy of Thrombotic Significance.
N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930. PubMedAbstract available
January 2025
HALL VG, Smibert OC, Sullivan SG, Lim C, et al Influenza Vaccination Strategies in Patients with Hematologic Cancer.
N Engl J Med. 2025;392:306-308. PubMed
December 2024
GARG S, Reinhart K, Couture A, Kniss K, et al Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.
N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMoa2414610. PubMedAbstract available
JASSEM AN, Roberts A, Tyson J, Zlosnik JEA, et al Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.
N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMc2415890. PubMed
October 2024
BLENDON RJ, Blumenthal D, Glied S, Sommers BD, et al Critical Health Care Challenges for the Next U.S. President.
N Engl J Med. 2024;391:e36. PubMed
September 2024
WALSH EE Creeping toward Effective Antiviral Agents for RSV Infection.
N Engl J Med. 2024;391:1155-1156. PubMed
ZHAO S, Shang Y, Yin Y, Zou Y, et al Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection.
N Engl J Med. 2024;391:1096-1107. PubMedAbstract available
What Exactly Is Long Covid?: ITT Episode 37.
N Engl J Med. 2024;391:e17. PubMed
TISZA MJ, Hanson BM, Clark JR, Wang L, et al Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten
Cities.
N Engl J Med. 2024 Sep 11. doi: 10.1056/NEJMc2405937. PubMed
ROTTER LK "Do You Feel Safe at Home?".
N Engl J Med. 2024;391:785-787. PubMed
WALENSKY RP, Baggett MV, Tran KM, Shepard JO, et al Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea.
N Engl J Med. 2024;391:845-852. PubMed
August 2024
DAVIS E, Mayer S, Pacilli M Academic Medical Center-Public Health Partnerships for Outbreak Response -
Collaborating with Underresourced Communities.
N Engl J Med. 2024;391:679-681. PubMed
HAYES C In Pursuit of Polka Dots.
N Engl J Med. 2024;391:582-583. PubMed
CANDRIAN C, Weissman JS, Tjia J SOGI Data Collection - Proceeding, but with Caution.
N Engl J Med. 2024;391:580-581. PubMed
HALABI S, O'Hara GL Preparing for the Next Pandemic - Expanding and Coordinating Global Regulatory
Capacity.
N Engl J Med. 2024;391:484-487. PubMed
MAKARI GJ, Friedman RA Collective Trauma and Commemoration - A Moment of Silence, Please.
N Engl J Med. 2024;391:487-489. PubMed
MIN J Studies of Exagamglogene Autotemcel - Age and Place.
N Engl J Med. 2024;391:571-572. PubMed
MORSE J, Coyle J, Mikesell L, Stoddard B, et al Influenza A(H5N1) Virus Infection in Two Dairy Farm Workers in Michigan.
N Engl J Med. 2024 Aug 7. doi: 10.1056/NEJMc2407264. PubMed
HAMMOND J, Fountaine RJ, Bao W Nirmatrelvir for Adult Outpatients with Covid-19. Reply.
N Engl J Med. 2024;391:478-479. PubMed
SHANG L, Wang Y, Cao B Nirmatrelvir for Adult Outpatients with Covid-19.
N Engl J Med. 2024;391:477-478. PubMed
BLAIS JE Nirmatrelvir for Adult Outpatients with Covid-19.
N Engl J Med. 2024;391:477. PubMed
SHAN D, Zhang G, Du Z Nirmatrelvir for Adult Outpatients with Covid-19.
N Engl J Med. 2024;391:477. PubMed
July 2024
SINHA MS, Parmet WE, Gonsalves GS Deja Vu All Over Again - Refusing to Learn the Lessons of Covid-19.
N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMp2406427. PubMed
HAMMOND J, Yunis C, Fountaine RJ, Luscan G, et al Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
N Engl J Med. 2024;391:224-234. PubMedAbstract available
MEISSNER HC, Kapogiannis BG, Wolfe DN Anticipating the Next Pandemic.
N Engl J Med. 2024;391:196-199. PubMed
ROSEN CJ Viral Variants, Vaccinations, and Long Covid - New Insights.
N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMe2407575. PubMed
XIE Y, Choi T, Al-Aly Z Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron
Eras.
N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211. PubMedAbstract available
ASSAD Z, Romain AS, Aupiais C, Shum M, et al Nirsevimab and Hospitalization for RSV Bronchiolitis.
N Engl J Med. 2024;391:144-154. PubMedAbstract available
June 2024
Are We Prepared for Bird Flu?: ITT Episode 32.
N Engl J Med. 2024;390:e59. PubMed
SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177. PubMedAbstract available
KAISER F, Morris DH, Wickenhagen A, Mukesh R, et al Inactivation of Avian Influenza A(H5N1) Virus in Raw Milk at 63 degrees C and 72 degrees C.
N Engl J Med. 2024 Jun 14. doi: 10.1056/NEJMc2405488. PubMed
OWUSU-ANSAH S, Green Rodgers P Reviving Hearts - Uniting Communities with Lifesaving Bystander CPR.
N Engl J Med. 2024;390:2040-2041. PubMed
HAMPSHIRE A, Elliott P Cognition and Memory after Covid-19 in a Large Community Sample. Reply.
N Engl J Med. 2024;390:2035. PubMed
XU L, Huang X, Li Y Cognition and Memory after Covid-19 in a Large Community Sample.
N Engl J Med. 2024;390:2034-2035. PubMed
BUONSENSO D Cognition and Memory after Covid-19 in a Large Community Sample.
N Engl J Med. 2024;390:2034. PubMed
May 2024
HALABI S, Gostin LO, Egbokhare O, Kavanagh MM, et al Global Health Law for a Safer and Fairer World.
N Engl J Med. 2024;390:1925-1931. PubMed
LIN DY, Du Y, Xu Y, Paritala S, et al Durability of XBB.1.5 Vaccines against Omicron Subvariants.
N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779. PubMed
GUAN L, Eisfeld AJ, Pattinson D, Gu C, et al Cow's Milk Containing Avian Influenza A(H5N1) Virus - Heat Inactivation and
Infectivity in Mice.
N Engl J Med. 2024 May 24. doi: 10.1056/NEJMc2405495. PubMed
RUBIN EJ, Baden LR, Daskalakis D, Marston H, et al Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
N Engl J Med. 2024 May 22. doi: 10.1056/NEJMe2406224. PubMed
RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al Audio Interview: The Current State of Avian Influenza.
N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223. PubMed
HERBERT C, McManus DD, Soni A False Positive Covid-19 Rapid Antigen Tests. Reply.
N Engl J Med. 2024;390:1836. PubMed
YANG C, Espin E, Tebbutt SJ False Positive Covid-19 Rapid Antigen Tests.
N Engl J Med. 2024;390:1835-1836. PubMed
SCHUBACH A, Ricotta D, Kittleson MM To Preround or Not to Preround.
N Engl J Med. 2024;390:1824-1826. PubMed
UYEKI TM, Milton S, Abdul Hamid C, Reinoso Webb C, et al Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
N Engl J Med. 2024 May 3. doi: 10.1056/NEJMc2405371. PubMed
April 2024
WANG Y, Hu H, Cao B Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
N Engl J Med. 2024;390:1534-1535. PubMed
SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
N Engl J Med. 2024;390:1534. PubMed
MOSER CB, Li JZ, Hughes MD Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
N Engl J Med. 2024;390:1533-1534. PubMed
GANDHI RT, Hirsch M Treating Acute Covid-19 - Final Chapters Still Unwritten.
N Engl J Med. 2024;390:1234-1236. PubMed
HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
N Engl J Med. 2024;390:1186-1195. PubMedAbstract available
March 2024
HSIAO A, Fireman B, Klein NP Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
N Engl J Med. 2024;390:1156. PubMed
WOO EJ, Hulse AN Recombinant Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2024;390:1155-1156. PubMed
HAVIARI S, Massonnaud CR, Dupont A Recombinant Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2024;390:1155. PubMed
DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other
Outcomes.
N Engl J Med. 2024;390:1009-1021. PubMedAbstract available
February 2024
ELLINGJORD-DALE M, Brunvoll SH, Soraas A Prospective Memory Assessment before and after Covid-19.
N Engl J Med. 2024;390:863-865. PubMed
AL-ALY Z, Rosen CJ Long Covid and Impaired Cognition - More Evidence and More Work to Do.
N Engl J Med. 2024;390:858-860. PubMed
HAMPSHIRE A, Azor A, Atchison C, Trender W, et al Cognition and Memory after Covid-19 in a Large Community Sample.
N Engl J Med. 2024;390:806-818. PubMedAbstract available
MONTO AS, Zambon M, Weir JP The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent
Vaccines.
N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801. PubMed
BENEZECH S, Khoryati L, Belot A More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
N Engl J Med. 2024;390:771-772. PubMed
FRANCO A, Tremoulet A, Burns JC More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
N Engl J Med. 2024;390:771. PubMed
HERBERT C, McManus DD, Soni A Persistent False Positive Covid-19 Rapid Antigen Tests.
N Engl J Med. 2024;390:764-765. PubMed
January 2024
MISSET B, Desmecht D, Laterre PF Convalescent Plasma for Covid-19-Induced ARDS. Reply.
N Engl J Med. 2024;390:386. PubMed
CASADEVALL A, Shoham S, Pirofski LA Convalescent Plasma for Covid-19-Induced ARDS.
N Engl J Med. 2024;390:385-386. PubMed
SENEFELD JW, Henderson JP, Joyner MJ Convalescent Plasma for Covid-19-Induced ARDS.
N Engl J Med. 2024;390:385. PubMed
BORGHESI A, Casanova JL Convalescent Plasma for Covid-19-Induced ARDS.
N Engl J Med. 2024;390:384-385. PubMed
CAO B, Wang Y, Lu H, Huang C, et al Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
N Engl J Med. 2024;390:230-241. PubMedAbstract available
December 2023
HALASA NB RSV Prevention - Breakthroughs and Challenges.
N Engl J Med. 2023;389:2480-2481. PubMed
DRYSDALE SB, Cathie K, Flamein F, Knuf M, et al Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.
N Engl J Med. 2023;389:2425-2435. PubMedAbstract available
Covid Update: ITT Episode 23.
N Engl J Med. 2023;389:e52. PubMed
HSIAO A, Yee A, Fireman B, Hansen J, et al Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age.
N Engl J Med. 2023;389:2245-2255. PubMedAbstract available
COHN AC, Hall AJ Continued Progress in the Development of Safe and Effective RSV Immunizations.
N Engl J Med. 2023;389:2289-2290. PubMed
WILSON E, Goswami J, Baqui AH, Doreski PA, et al Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
N Engl J Med. 2023;389:2233-2244. PubMedAbstract available
November 2023
BENEZECH S, Khoryati L, Cognard J, Netea SA, et al Pre-Covid-19, SARS-CoV-2-Negative Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2023;389:2105-2107. PubMed
WANG Y, Guo Z, Ye B, Liu L, et al Association of SARS-CoV-2 Infection during Early Weeks of Gestation with Situs
Inversus.
N Engl J Med. 2023;389:1722-1724. PubMed
October 2023
MISSET B, Piagnerelli M, Hoste E, Dardenne N, et al Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated
Patients.
N Engl J Med. 2023;389:1590-1600. PubMedAbstract available
BLADH O, Greilert-Norin N, Havervall S, Marking U, et al Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.
N Engl J Med. 2023;389:1626-1628. PubMed
HILLS TE, Lorenzi E, Berry LR, Shyamsundar M, et al Simvastatin in Critically Ill Patients with Covid-19.
N Engl J Med. 2023 Oct 25. doi: 10.1056/NEJMoa2309995. PubMedAbstract available
The Long Haul of Long Covid.
N Engl J Med. 2023;389:e29. PubMed
ABI-RACHED JM, Brandt AM Do Pandemics Ever End?
N Engl J Med. 2023;389:1349-1351. PubMed
September 2023
BOULWARE DR, Lindsell CJ, Stewart TG, Hernandez AF, et al Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.
N Engl J Med. 2023;389:1085-1095. PubMedAbstract available
August 2023
MURRAY EJ, Cowger TL, Hall KT Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
Reply.
N Engl J Med. 2023;389:580. PubMed
MARINE JE Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579. PubMed
LADHANI SN, Andrews N, Ramsay ME Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579. PubMed
RUSSELL FM, Curtis N, Carlin J Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:578-579. PubMed
KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
N Engl J Med. 2023;389:474-475. PubMed
July 2023
BECERRA X, Jha A Project NextGen - Defeating SARS-CoV-2 and Preparing for the Next Pandemic.
N Engl J Med. 2023 Jul 26. doi: 10.1056/NEJMp2307867. PubMed
ARBEL R, Sergienko R, Netzer D, Hammerman A, et al Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against
Covid-19. Reply.
N Engl J Med. 2023;389:285-286. PubMed
HOEG TB, Duriseti R, Prasad V Potential "Healthy Vaccinee Bias" in a Study of BNT162b2 Vaccine against
Covid-19.
N Engl J Med. 2023;389:284-285. PubMed
MCCRINDLE BW, Manlhiot C More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
Reply.
N Engl J Med. 2023;389:287-288. PubMed
XIA CY, Niu MM, Hu P More on SARS-CoV-2 Variants and Pediatric Multisystem Inflammatory Syndrome.
N Engl J Med. 2023;389:287. PubMed
PITTET LF, Messina NL, Curtis N BCG to Protect against Covid-19 in Health Care Workers. Reply.
N Engl J Med. 2023;389:192. PubMed
BENN CS, Netea MG, Aaby P BCG to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;389:191-192. PubMed
LOPEZ-CAMPOS GH, Valvano MA BCG to Protect against Covid-19 in Health Care Workers.
N Engl J Med. 2023;389:191. PubMed
June 2023
HALABI S, Wilder R, Gostin LO, Hurtado ML, et al Sharing Pathogen Genomic Sequence Data - Toward Effective Pandemic Prevention,
Preparedness, and Response.
N Engl J Med. 2023;388:2401-2404. PubMed
CAO Z, Gao Y, Zhao R VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
N Engl J Med. 2023;388:2396-2397. PubMed
LI Y VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2396. PubMed
EDWARDS JL VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395-2396. PubMed
BERGMANN F, Jorda A, Zeitlinger M VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395. PubMed
LIN DY, Fleming TR VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
N Engl J Med. 2023;388:2395. PubMed
MCGARRY BE, Gandhi AD, Barnett ML Covid-19 Surveillance Testing in Nursing Homes. Reply.
N Engl J Med. 2023;388:2207-2208. PubMed
STALL NM, Kain DC, Johnstone J Covid-19 Surveillance Testing in Nursing Homes.
N Engl J Med. 2023;388:2207. PubMed
DORFMAN D, Berger Z Approving Workplace Accommodations for Patients with Long Covid - Advice for
Clinicians.
N Engl J Med. 2023;388:2115-2117. PubMed
NIKOLICH JZ, Rosen CJ Toward Comprehensive Care for Long Covid.
N Engl J Med. 2023;388:2113-2115. PubMed
GOSTIN LO, Gronvall GK The Origins of Covid-19 - Why It Matters (and Why It Doesn't).
N Engl J Med. 2023 Jun 7. doi: 10.1056/NEJMp2305081. PubMed
TSUBOI M, Herbst RS, John T, Kato T, et al Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304594. PubMedAbstract available
REIS G, Mills EJ, Glenn JS Pegylated Interferon Lambda for Covid-19. Reply.
N Engl J Med. 2023;388:2108. PubMed
WANG M, Tang L, Huang L Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:2107-2108. PubMed
ANDREAKOS E, Tsiodras S Pegylated Interferon Lambda for Covid-19.
N Engl J Med. 2023;388:2107. PubMed
May 2023
RUBIN EJ, Baden LR, Morrissey S Audio Interview: The Lasting Effects of Covid-19.
N Engl J Med. 2023;388:e76. PubMed
RUBIN EJ, Baden LR, Morrissey S Audio Interview: Ending the Covid-19 Emergency.
N Engl J Med. 2023;388:e72. PubMed
LISCO A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
N Engl J Med. 2023;388:1680-1691. PubMedAbstract available
April 2023
PITTET LF, Messina NL, Orsini F, Moore CL, et al Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care
Workers.
N Engl J Med. 2023;388:1582-1596. PubMedAbstract available
KARRON RA RSV Illness in the Young and the Old - The Beginning of the End?
N Engl J Med. 2023;388:1522-1524. PubMed
RUBIN EJ, Baden LR, Morrissey S Audio Interview: When to Get a Second Covid-19 Booster Shot.
N Engl J Med. 2023;388:e64. PubMed
ADAMS G, Moreno GK, Petros BA, Uddin R, et al Viral Lineages in the 2022 RSV Surge in the United States.
N Engl J Med. 2023;388:1335-1337. PubMed
KAMPMANN B, Madhi SA, Munjal I, Simoes EAF, et al Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2216480. PubMedAbstract available
MULLER WJ, Madhi SA, Seoane Nunez B, Baca Cots M, et al Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMc2214773. PubMed
WALSH EE, Perez Marc G, Zareba AM, Falsey AR, et al Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
N Engl J Med. 2023 Apr 5. doi: 10.1056/NEJMoa2213836. PubMedAbstract available
March 2023
RUBIN EJ, Baden LR, Morrissey S Audio Interview: Ending the Covid-19 Public Health Emergency.
N Engl J Med. 2023;388:e53. PubMed
JABAGI MJ, Bertrand M, Botton J, Le Vu S, et al Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134. PubMed
NEUZIL KM An mRNA Influenza Vaccine - Could It Deliver?
N Engl J Med. 2023;388:1139-1141. PubMed
MCGARRY BE, Gandhi AD, Barnett ML Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes.
N Engl J Med. 2023;388:1101-1110. PubMedAbstract available
MCCRINDLE BW, Harahsheh AS, Handoko R, Raghuveer G, et al SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children.
N Engl J Med. 2023 Mar 22. doi: 10.1056/NEJMc2215074. PubMed
RUBIN EJ, Baden LR, Morrissey S Audio Interview: The Future of Covid-19 Research.
N Engl J Med. 2023;388:e39. PubMed
MANSOUR MK, King JD, Chen ST, Fishman JA, et al Case 7-2023: A 70-Year-Old Man with Covid-19, Respiratory Failure, and Rashes.
N Engl J Med. 2023;388:926-937. PubMed
RUBIN EJ, Baden LR, Morrissey S Audio Interview: The Path Forward for Covid-19 Therapeutics.
N Engl J Med. 2023;388:e36. PubMed
OFFIT PA Bivalent Covid-19 Vaccines. Reply.
N Engl J Med. 2023;388:10. PubMed
MARKS PW, Califf RM Bivalent Covid-19 Vaccines.
N Engl J Med. 2023;388:10. PubMed
LI D, Duan M, Wang X, Gao P, et al Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines.
N Engl J Med. 2023 Mar 1. doi: 10.1056/NEJMc2216233. PubMed
February 2023
HUTH L, Schafer L, Almanzar G, Lupoli G, et al Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis.
N Engl J Med. 2023 Feb 15. doi: 10.1056/NEJMc2216309. PubMed
January 2023
ZOU J, Kurhade C, Patel S, Kitchin N, et al Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent
Vaccine.
N Engl J Med. 2023 Jan 25. doi: 10.1056/NEJMc2214916. PubMed
September 2021
AMIT S, Gonen T, Regev-Yochay G Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
N Engl J Med. 2021;385. PubMed
JUNG J, Sung H, Kim SH Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
N Engl J Med. 2021;385. PubMed
JONES DS, Podolsky SH Mask Wars.
N Engl J Med. 2021;385:1159-1161. PubMed